AABB interviewed Phil Accooe, MBA, MS, MLS(ASCP)SBB, CLS, CABP, PMP. He is a Supervisor at Transfusion Service Laboratory (TSL) and an AABB board member.

Phil Accooe
Phil Accooe, MBA, MS,
MLS(ASCP)SBB, CLS, CABP, PMP

CABP Interview February 2023: Phil Accooe, MBA, MS, MLS(ASCP)SBB, CLS, CABP, PMP

What is your name, where are you from, what do you do – tell us a bit about yourself?

My name is Phil Accooe. I’m originally from New Jersey, but I currently live in Long Beach, California, where I work as a transfusion service laboratory supervisor.

What first attracted you to biotherapies?

I first developed an interest in biotherapies during my Specialists in Blood Bank (SBB) program at the National Institutes of Health. The options for our individual research project comprised biotherapies, human leukocyte antigens (HLA), or antigen expression on cultured red blood cells. The biotherapies aspect of the field seemed like it had a lot more opportunity for discovery to me at the time, so I chose that for my project.

How did you first get involved with AABB?

I first became involved with AABB when I presented my SBB research project (focusing on biotherapies) as an oral abstract during the AABB Annual Meeting.

Why was it important to you to pursue the CABP certification?

I wanted a way to distinguish myself from other individuals when pursuing opportunities in the biotherapies field. My Medical Laboratory Scientist (MLS) & SBB credentials don’t reflect my experience manufacturing HPCs and somatic cell therapies. The CABP certification notifies others that I am a subject matter expert in biotherapies.

Phil Accooe

“The field of biotherapies is fairly novel and very complex. Hiring an individual is a big investment when you’re not certain whether or not they are fully qualified for the position. The CABP program can help bolster confidence that the appropriate hiring decision is being made.”

How can the CABP program help address some of the current challenges in the biotherapies field?

Before the CABP certification, there was no way to identify qualified individuals who were knowledgeable in biotherapies. We have credentials for other areas within laboratory medicine, but none of them specifically applied to biotherapies. One of the major challenges in the biotherapies field is the lack of qualified workforce. The field of biotherapies is fairly novel and very complex. Hiring an individual is a big investment when you’re not certain whether or not they are fully qualified for the position. The CABP program can help bolster confidence that the appropriate hiring decision is being made.

What other types of professionals do you think should consider registering for the CABP exam and why?

I think it’s relevant to a lot of professional groups. physicians, nurses, scientists, transplant coordinators, quality assurance professionals, and biotherapy sales/marketing professionals. The list goes on.

What are you most excited to work on in the next year?

I’m excited to start exploring more biotherapy opportunities with my newly acquired credential.

AABB Biotherapies Lab

Become a Certificated Advanced Biotherapies Professional (CABP)

Becoming a CABP is a mark of distinction, establishing that qualified professionals have demonstrated – through a certification exam – that they have the necessary knowledge to credibly practice in the field of biotherapies.

Learn More